170 related articles for article (PubMed ID: 35715659)
1. Glycan expression profile of signet ring cell gastric cancer cells and potential applicability of rBC2LCN-targeted lectin drug conjugate therapy.
Yang Y; Akashi Y; Shimomura O; Tateno H; Saito S; Hiemori K; Miyazaki Y; Furuta T; Kitaguchi D; Kuroda Y; Pakavarin L; Oda T
Gastric Cancer; 2022 Sep; 25(5):896-905. PubMed ID: 35715659
[TBL] [Abstract][Full Text] [Related]
2. Lectin drug conjugate therapy for colorectal cancer.
Kitaguchi D; Oda T; Enomoto T; Ohara Y; Owada Y; Akashi Y; Furuta T; Yu Y; Kimura S; Kuroda Y; Kurimori K; Miyazaki Y; Furuya K; Shimomura O; Tateno H
Cancer Sci; 2020 Dec; 111(12):4548-4557. PubMed ID: 33058342
[TBL] [Abstract][Full Text] [Related]
3. Novel Pancreatic Cancer Therapy Targeting Cell Surface Glycans by Liposomes Modified with rBC2LCN Lectin.
Kimura S; Oda T; Shimomura O; Enomoto T; Hashimoto S; Kuroda Y; Yu Y; Kurimori K; Furuta T; Miyazaki Y; Tateno H
Eur Surg Res; 2020; 61(4-5):113-122. PubMed ID: 33503609
[TBL] [Abstract][Full Text] [Related]
4. A Novel Therapeutic Strategy for Pancreatic Cancer: Targeting Cell Surface Glycan Using rBC2LC-N Lectin-Drug Conjugate (LDC).
Shimomura O; Oda T; Tateno H; Ozawa Y; Kimura S; Sakashita S; Noguchi M; Hirabayashi J; Asashima M; Ohkohchi N
Mol Cancer Ther; 2018 Jan; 17(1):183-195. PubMed ID: 28939555
[TBL] [Abstract][Full Text] [Related]
5. Enhanced expression of α2,3-linked sialic acids promotes gastric cancer cell metastasis and correlates with poor prognosis.
Shen L; Luo Z; Wu J; Qiu L; Luo M; Ke Q; Dong X
Int J Oncol; 2017 Apr; 50(4):1201-1210. PubMed ID: 28259967
[TBL] [Abstract][Full Text] [Related]
6. Podocalyxin is a glycoprotein ligand of the human pluripotent stem cell-specific probe rBC2LCN.
Tateno H; Matsushima A; Hiemori K; Onuma Y; Ito Y; Hasehira K; Nishimura K; Ohtaka M; Takayasu S; Nakanishi M; Ikehara Y; Nakanishi M; Ohnuma K; Chan T; Toyoda M; Akutsu H; Umezawa A; Asashima M; Hirabayashi J
Stem Cells Transl Med; 2013 Apr; 2(4):265-73. PubMed ID: 23526252
[TBL] [Abstract][Full Text] [Related]
7. Rapidly declining trend of signet ring cell cancer of the stomach may parallel the infection rate of Helicobacter pylori.
Ohyama H; Yoshimura D; Hirotsu Y; Amemiya K; Amano H; Miura Y; Ashizawa H; Nakagomi K; Takaoka S; Hosoda K; Suzuki Y; Oyama T; Hada M; Kojima Y; Mochizuki H; Omata M
BMC Gastroenterol; 2019 Nov; 19(1):178. PubMed ID: 31703565
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological characteristics of signet ring cell carcinoma of the stomach.
Kim DY; Park YK; Joo JK; Ryu SY; Kim YJ; Kim SK; Lee JH
ANZ J Surg; 2004 Dec; 74(12):1060-4. PubMed ID: 15574148
[TBL] [Abstract][Full Text] [Related]
9. Differences in clinicopathological characteristics and computed tomography findings between signet ring cell carcinoma and nonsignet ring cell carcinoma in early and advanced gastric cancer.
Chen J; Cai R; Ren G; Zhao J; Li H; Guo C; He W; Wu X; Zhang W
Cancer Med; 2018 Apr; 7(4):1160-1169. PubMed ID: 29533002
[TBL] [Abstract][Full Text] [Related]
10. Carcinoembryonic antigen as a specific glycoprotein ligand of rBC2LCN lectin on pancreatic ductal adenocarcinoma cells.
Furuta T; Oda T; Kiyoi K; Yusuke O; Kimura S; Kurimori K; Miyazaki Y; Yu Y; Furuya K; Akashi Y; Shimomura O; Tateno H
Cancer Sci; 2021 Sep; 112(9):3722-3731. PubMed ID: 34115906
[TBL] [Abstract][Full Text] [Related]
11. Gastric Signet Ring Cell Carcinoma: A Comparative Analysis of Clinicopathologic Features.
Efared B; Kadi M; Tahiri L; Lahmidani N; Hassani KM; Bouhaddouti HE; Benbrahim Z; Adil IS; Chbani L
Cancer Control; 2020; 27(1):1073274820976596. PubMed ID: 33269609
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological Characteristics and Survival Outcomes of Primary Signet Ring Cell Carcinoma in the Stomach: Retrospective Analysis of Single Center Database.
Liu X; Cai H; Sheng W; Yu L; Long Z; Shi Y; Wang Y
PLoS One; 2015; 10(12):e0144420. PubMed ID: 26642199
[TBL] [Abstract][Full Text] [Related]
13. Advanced gastric carcinoma with signet ring cell carcinoma versus non-signet ring cell carcinoma: differentiation with multidetector CT.
Lee JH; Park MS; Kim KW; Yu JS; Kim MJ; Yang SW; Lee YC
J Comput Assist Tomogr; 2006; 30(6):880-4. PubMed ID: 17082689
[TBL] [Abstract][Full Text] [Related]
14. Advanced gastric carcinoma with signet ring cell histology.
Li C; Kim S; Lai JF; Hyung WJ; Choi WH; Choi SH; Noh SH
Oncology; 2007; 72(1-2):64-8. PubMed ID: 18004078
[TBL] [Abstract][Full Text] [Related]
15. Glycoprofiling of Early Gastric Cancer Using Lectin Microarray Technology.
Li T; Mo C; Qin X; Li S; Liu Y; Liu Z
Clin Lab; 2018 Jan; 64(1):153-161. PubMed ID: 29479898
[TBL] [Abstract][Full Text] [Related]
16. Identification of aberrantly expressed glycans in gastric cancer by integrated lectin microarray and mass spectrometric analyses.
Li X; Guan F; Li D; Tan Z; Yang G; Wu Y; Huang Z
Oncotarget; 2016 Dec; 7(52):87284-87300. PubMed ID: 27895315
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of mismatch repair genes is less frequently observed in signet ring cell compared with non-signet ring cell gastric cancer.
Hirotsu Y; Mochizuki H; Amemiya K; Ohyama H; Yoshimura D; Amano H; Miura Y; Ashizawa H; Nakagomi K; Takaoka S; Hosoda K; Suzuki Y; Oyama T; Hada M; Kojima Y; Omata M
Med Oncol; 2019 Jan; 36(3):23. PubMed ID: 30694393
[TBL] [Abstract][Full Text] [Related]
18. Use of lectin microarray to differentiate gastric cancer from gastric ulcer.
Huang WL; Li YG; Lv YC; Guan XH; Ji HF; Chi BR
World J Gastroenterol; 2014 May; 20(18):5474-82. PubMed ID: 24833877
[TBL] [Abstract][Full Text] [Related]
19. Engineering of a Potent Recombinant Lectin-Toxin Fusion Protein to Eliminate Human Pluripotent Stem Cells.
Tateno H; Saito S
Molecules; 2017 Jul; 22(7):. PubMed ID: 28698527
[TBL] [Abstract][Full Text] [Related]
20. Glycome analysis of extracellular vesicles derived from human induced pluripotent stem cells using lectin microarray.
Saito S; Hiemori K; Kiyoi K; Tateno H
Sci Rep; 2018 Mar; 8(1):3997. PubMed ID: 29507392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
